In early March 2017, American College of Rheumatology (ACR) President Sharad Lakhanpal, MBBS, MD, released a statement asserting the ACR’s position on the controversial American Health Care Act (AHCA).
Former President Barack Obama signed the 21st Century Cures Act into law.1 This legislation will allocate approximately $4.8 billion in crucial funding for medical research at the National Institutes of Health (NIH) that will span the next 10 years, including $1.4 billion for the Precision Medicine Initiative, $1.8 billion for the Brain Research Through Advancing Innovative Neurotechnologies Initiative, and $1.8 billion for the Cancer Moonshot initiative.2,3
Read Now
Stay up to date with rheumatology news & updates by subscribing to receive the free RPM print publications or weekly e‑Newsletter.